Neurotrophic factors in Alzheimer's disease: Role of axonal transport

Genes, Brain and Behavior

Volumn 7, Issue SUPPL. 1, 2008, Pages 43-56

  Schindowski, K ^a,b,c   Belarbi, K ^a,b   Buee L ^a,b  

^a JEAN PIERRE AUBERT RESEARCH CENTER   (France)

^b UNIV LILLE   (France)

^c INSERM   (France)

Author keywords

Abeta; APP; BDNF; Cholinergic neurons; Dementia; Neurodegeneration; NGF; NT 3; NT 4 5; Tau

Indexed keywords

AMYLOID BETA PROTEIN; BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR; NERVE GROWTH FACTOR; NEUROTROPHIC FACTOR; NEUROTROPHIN 3; NEUROTROPHIN 3 RECEPTOR; NEUROTROPHIN 4; NEUROTROPHIN RECEPTOR P75; PROTEIN TYROSINE KINASE A;

ALZHEIMER DISEASE; CELL FUNCTION; CELL SURVIVAL; CHOLINERGIC NERVE CELL; COGNITION; CONFERENCE PAPER; CONTROLLED STUDY; DEGENERATIVE DISEASE; HIPPOCAMPUS; HUMAN; HUMAN CELL; HUMAN TISSUE; LEARNING; MEMORY; NEOCORTEX; NERVE CELL PLASTICITY; NERVE FIBER TRANSPORT; NEUROFIBRILLARY TANGLE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN LOCALIZATION; RETROGRADE NERVE FIBER TRANSPORT;

EID: 37849050242     PISSN: 16011848     EISSN: 1601183X     Source Type: Journal    
DOI: 10.1111/j.1601-183X.2007.00378.x     Document Type: Conference Paper

References (199)

1. Adalbert, R., Gilley, J. Coleman, M.P 2007) Abeta, tau and ApoE4 in Alzheimer's disease: the axonal connection. Trends Mol Med 13, 135 142.
2. Akatsu, H., Yamagata, H.D., Kawamata, J., Kamino, K., Takeda, M., Yamamoto, T., Miki, T., Tooyama, I., Shimohama, S. Kosaka, K 2006) Variations in the BDNF gene in autopsy-confirmed Alzheimer's disease and dementia with Lewy bodies in Japan. Dement Geriatr Cogn Disord 22, 216 222.
3. Allen, S.J., Wilcock, G.K. Dawbarn, D 1999) Profound and selective loss of catalytic TrkB immunoreactivity in Alzheimer's disease. Biochem Biophys Res Commun 264, 648 651.
4. Ambree, O., Leimer, U., Herring, A., Gortz, N., Sachser, N., Heneka, M.T., Paulus, W. Keyvani, K 2006) Reduction of amyloid angiopathy and Abeta plaque burden after enriched housing in TgCRND8 mice: involvement of multiple pathways. Am J Pathol 169, 544 552.
5. Araujo, D.M. Cotman, C.W 1992) Basic FGF in astroglial, microglial, and neuronal cultures: characterization of binding sites and modulation of release by lymphokines and trophic factors. J Neurosci 12, 1668 1678.
6. Arenas, E. Persson, H 1994) Neurotrophin-3 prevents the death of adult central noradrenergic neurons in vivo. Nature 367, 368 371.
7. Arendt, T., Bigl, V., Arendt, A. Tennstedt, A 1983) Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's disease. Acta Neuropathol (Berl) 61, 101 108.
8. Babu, J.R., Geetha, T. Wooten, M.W 2005) Sequestosome 1/p62 shuttles polyubiquitinated tau for proteasomal degradation. J Neurochem 94, 192 203.
9. Barghorn, S., Nimmrich, V., Striebinger, A., Krantz, C., Keller, P., Janson, B., Bahr, M., Schmidt, M., Bitner, R.S., Harlan, J., Barlow, E., Ebert, U. Hillen, H 2005) Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease. J Neurochem 95, 834 847.
10. Bauer, M., Alda, M., Priller, J. Young, L.T 2003) Implications of the neuroprotective effects of lithium for the treatment of bipolar and neurodegenerative disorders. Pharmacopsychiatry 36 (Suppl. 3 S250 S254.
11. Bergeron, C., Pollanen, M.S., Weyer, L. Lang, A.E 1997) Cortical degeneration in progressive supranuclear palsy. A comparison with cortical-basal ganglionic degeneration. J Neuropathol Exp Neurol 56, 726 734.
12. Bian, J.T., Zhang, J.W., Zhang, Z.X. Zhao, H.L 2005) Association analysis of brain-derived neurotrophic factor (BDNF) gene 196 A/G polymorphism with Alzheimer's disease (AD) in mainland Chinese. Neurosci Lett 387, 11 16.
13. Boissiere, F., Hunot, S., Faucheux, B., Hersh, L.B., Agid, Y. Hirsch, E.C 1997) Trk neurotrophin receptors in cholinergic neurons of patients with Alzheimer's disease. Dement Geriatr Cogn Disord 8, 1 8.
14. Braak, H. Braak, E 1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl) 82, 239 259.
15. Brendza, R.P., Simmons, K., Bales, K.R., Paul, S.M., Goldberg, M.P. Holtzman, D.M 2003) Use of YFP to study amyloid-beta associated neurite alterations in live brain slices. Neurobiol Aging 24, 1071 1077.
16. Burack, M.A. Halpain, S 1996) Site-specific regulation of Alzheimer-like tau phosphorylation in living neurons. Neuroscience 72, 167 184.
17. Burbach, G.J., Hellweg, R., Haas, C.A., Del Turco, D., Deicke, U., Abramowski, D., Jucker, M., Staufenbiel, M. Deller, T 2004) Induction of brain-derived neurotrophic factor in plaque-associated glial cells of aged APP23 transgenic mice. J Neurosci 24, 2421 2430.
18. Busciglio, J., Lorenzo, A., Yeh, J. Yankner, B.A 1995) Beta-amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron 14, 879 888.
19. Butt, A.M. Dinsdale, J 2005) Fibroblast growth factor 2 mediated disruption of myelin-forming oligodendrocytes in vivo is associated with increased tau immunoreactivity. Neurosci Lett 375, 28 32.
20. Capsoni, S., Giannotta, S. Cattaneo, A 2002) Nerve growth factor and galantamine ameliorate early signs of neurodegeneration in anti-nerve growth factor mice. Proc Natl Acad Sci U S A 99, 12432 12437.
21. Carlson, G.A., Borchelt, D.R., Dake, A., Turner, S., Danielson, V., Coffin, J.D., Eckman, C., Meiners, J., Nilsen, S.P., Younkin, S.G. Hsiao, K.K 1997) Genetic modification of the phenotypes produced by amyloid precursor protein overexpression in transgenic mice. Hum Mol Genet 6, 1951 1959.
22. Chee, F.C., Mudher, A., Cuttle, M.F., Newman, T.A., MacKay, D., Lovestone, S. Shepherd, D 2005) Over-expression of tau results in defective synaptic transmission in Drosophila neuromuscular junctions. Neurobiol Dis 20, 918 928.
23. Chen, M.J. Russo-Neustadt, A.A 2005) Exercise activates the phosphatidylinositol 3-kinase pathway. Brain Res Mol Brain Res 135, 181 193.
24. Cheng, B. Mattson, M.P 1992) Glucose deprivation elicits neurofibrillary tangle-like antigenic changes in hippocampal neurons: prevention by NGF and bFGF. Exp Neurol 117, 114 123.
25. Chu, Y., Cochran, E.J., Bennett, D.A., Mufson, E.J. Kordower, J.H 2001) Down-regulation of trkA mRNA within nucleus basalis neurons in individuals with mild cognitive impairment and Alzheimer's disease. J Comp Neurol 437, 296 307.
26. Chuang, D.M 2004) Neuroprotective and neurotrophic actions of the mood stabilizer lithium: can it be used to treat neurodegenerative diseases? Crit Rev Neurobiol 16, 83 90.
27. Chuu, J.Y., Taylor, J.L., Tinklenberg, J., Noda, A., Yesavage, J. Murphy, G.M. Jr. (2006) The brain-derived neurotrophic factor Val66Met polymorphism and rate of decline in Alzheimer's disease. J Alzheimers Dis 9, 43 49.
28. Cirrito, J.R., Yamada, K.A., Finn, M.B., Sloviter, R.S., Bales, K.R., May, P.C., Schoepp, D.D., Paul, S.M., Mennerick, S. Holtzman, D.M 2005) Synaptic activity regulates interstitial fluid amyloid-b levels in vivo. Neuron 48, 913 922.
29. Combarros, O., Infante, J., Llorca, J. Berciano, J 2004) Polymorphism at codon 66 of the brain-derived neurotrophic factor gene is not associated with sporadic Alzheimer's disease. Dement Geriatr Cogn Disord 18, 55 58.
30. Connor, B., Young, D., Lawlor, P., Gai, W., Waldvogel, H., Faull, R.L. Dragunow, M 1996) Trk receptor alterations in Alzheimer's disease. Brain Res Mol Brain Res 42, 1 17.
31. Connor, B., Young, D., Yan, Q., Faull, R.L., Synek, B. Dragunow, M 1997) Brain-derived neurotrophic factor is reduced in Alzheimer's disease. Brain Res Mol Brain Res 49, 71 81.
32. Costantini, C., Weindruch, R., Della Valle, G. Puglielli, L 2005) A TrkA-to-p75NTR molecular switch activates amyloid beta-peptide generation during aging. Biochem J 391, 59 67.
33. Costantini, C., Scrable, H. Puglielli, L 2006) An aging pathway controls the TrkA to p75NTR receptor switch and amyloid beta-peptide generation. EMBO J 25, 1997 2006.
34. Counts, S.E., Nadeem, M., Wuu, J., Ginsberg, S.D., Saragovi, H.U. Mufson, E.J 2004) Reduction of cortical TrkA but not p75(NTR) protein in early-stage Alzheimer's disease. Ann Neurol 56, 520 531.
35. Crutcher, K.A., Scott, S.A., Liang, S., Everson, W.V. Weingartner, J 1993) Detection of NGF-like activity in human brain tissue: increased levels in Alzheimer's disease. J Neurosci 13, 2540 2550.
36. Cummings, B.J., Su, J.H. Cotman, C.W 1993) Neuritic involvement within bFGF immunopositive plaques of Alzheimer's disease. Exp Neurol 124, 315 325.
37. da Penha Berzaghi, M., Cooper, J., Castrén, E., Zafra, F., Sofroniew, M., Thoenen, H. Lindholm, D 1993) Cholinergic regulation of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) but not neurotrophin-3 (NT-3) mRNA levels in the developing rat hippocampus. J Neurosci 13, 3813 3826.
38. Delacourte, A., Sergeant, N., Champain, D., Wattez, A., Maurage, C.A., Lebert, F., Pasquier, F. David, J.P 2002) Nonoverlapping but synergetic tau and APP pathologies in sporadic Alzheimer's disease. Neurology 59, 398 407.
39. De Rosa, R., Garcia, A.A., Braschi, C., Capsoni, S., Maffei, L., Berardi, N. Cattaneo, A 2005) Intranasal administration of nerve growth factor (NGF) rescues recognition memory deficits in AD11 anti-NGF transgenic mice. Proc Natl Acad Sci U S A 102, 3811 3816.
40. Desai, P., Nebes, R., DeKosky, S.T. Kamboh, M.I 2005) Investigation of the effect of brain-derived neurotrophic factor (BDNF) polymorphisms on the risk of late-onset Alzheimer's disease (AD) and quantitative measures of AD progression. Neurosci Lett 379, 229 234.
41. Durany, N., Michel, T., Kurt, J., Cruz-Sanchez, F.F., Cervas-Navarro, J. Riederer, P 2000) Brain-derived neurotrophic factor and neurotrophin-3 levels in Alzheimer's disease brains. Int J Dev Neurosci 18, 807 813.
42. Elliott, E. Ginzburg, I 2006) The role of neurotrophins and insulin on tau pathology in Alzheimer's disease. Rev Neurosci 17, 635 642.
43. Elliott, E., Atlas, R., Lange, A. Ginzburg, I 2005) Brain-derived neurotrophic factor induces a rapid dephosphorylation of tau protein through a PI-3 kinase signalling mechanism. Eur J Neurosci 22, 1081 1089.
44. Fahnestock, M., Scott, S.A., Jette, N., Weingartner, J.A. Crutcher, K.A 1996) Nerve growth factor mRNA and protein levels measured in the same tissue from normal and Alzheimer's disease parietal cortex. Brain Res Mol Brain Res 42, 175 178.
45. Fahnestock, M., Michalski, B., Xu, B. Coughlin, M.D 2001) The precursor pro-nerve growth factor is the predominant form of nerve growth factor in brain and is increased in Alzheimer's disease. Mol Cell Neurosci 18, 210 220.
46. Ferrer, I. Marti, E 1998) Distribution of fibroblast growth factor receptor-1 (FGFR-1) and FGFR-3 in the hippocampus of patients with Alzheimer's disease. Neurosci Lett 240, 139 142.
47. Ferrer, I., Marin, C., Rey, M.J., Ribalta, T., Goutan, E., Blanco, R., Tolosa, E. Marti, E 1999) BDNF and full-length and truncated TrkB expression in Alzheimer disease. Implications in therapeutic strategies. J Neuropathol Exp Neurol 58, 729 739.
48. Ferri, C.P., Prince, M., Brayne, C., Brodaty, H., Fratiglioni, L., Ganguli, M., Hall, K., Hasegawa, K., Hendrie, H., Huang, Y., Jorm, A., Mathers, C., Menezes, P.R., Rimmer, E. Scazufca, M 2005) Global prevalence of dementia: a Delphi consensus study. Lancet 366, 2112 2117.
49. Fisher, A., Heldman, E., Gurwitz, D., Haring, R., Karton, Y., Meshulam, H., Pittel, Z., Marciano, D., Brandeis, R., Sadot, E., Barg, Y., Pinkas-Kramarski, R., Vogel, Z., Ginzburg, I., Treves, T.A., Verchovsky, R., Klimowsky, S. Korczyn, A.D 1996) M1 agonists for the treatment of Alzheimer's disease. Novel properties and clinical update. Ann N Y Acad Sci 777, 189 196.
50. Forero, D.A., Benitez, B., Arboleda, G., Yunis, J.J., Pardo, R. Arboleda, H 2006) Analysis of functional polymorphisms in three synaptic plasticity-related genes (BDNF, COMT AND UCHL1) in Alzheimer's disease in Colombia. Neurosci Res 55, 334 341.
51. Frey, B.N., Andreazza, A.C., Cereser, K.M., Martins, M.R., Valvassori, S.S., Reus, G.Z., Quevedo, J. Kapczinski, F 2006a) Effects of mood stabilizers on hippocampus BDNF levels in an animal model of mania. Life Sci 79, 281 286.
52. Frey, B.N., Andreazza, A.C., Rosa, A.R., Martins, M.R., Valvassori, S.S., Reus, G.Z., Hatch, J.P., Quevedo, J. Kapczinski, F 2006b) Lithium increases nerve growth factor levels in the rat hippocampus in an animal model of mania. Behav Pharmacol 17, 311 318.
53. Friedman, W.J 2000) Neurotrophins induce death of hippocampal neurons via the p75 receptor. J Neurosci 20, 6340 6346.
54. Garzon, D., Yu, G. Fahnestock, M 2002) A new brain-derived neurotrophic factor transcript and decrease in brain-derived neurotrophic factor transcripts 1, 2 and 3 in Alzheimer's disease parietal cortex. J Neurochem 82, 1058 1064.
55. Garzon, D.J. Fahnestock, M 2007) Oligomeric amyloid decreases basal levels of brain-derived neurotrophic factor (BDNF) mRNA via specific downregulation of BDNF transcripts IV and V in differentiated human neuroblastoma cells. J Neurosci 27, 2628 2635.
56. Ge, Y.W. Lahiri, D.K 2002) Regulation of promoter activity of the APP gene by cytokines and growth factors: implications in Alzheimer's disease. Ann N Y Acad Sci 973, 463 467.
57. Giacobini, E 2003) Cholinesterases: new roles in brain function and in Alzheimer's disease. Neurochem Res 28, 515 522.
58. Ginsberg, S.D., Che, S., Counts, S.E. Mufson, E.J 2006a) Shift in the ratio of three-repeat tau and four-repeat tau mRNAs in individual cholinergic basal forebrain neurons in mild cognitive impairment and Alzheimer's disease. J Neurochem 96, 1401 1408.
59. Ginsberg, S.D., Che, S., Wuu, J., Counts, S.E. Mufson, E.J 2006b) Down regulation of trk but not p75NTR gene expression in single cholinergic basal forebrain neurons mark the progression of Alzheimer's disease. J Neurochem 97, 475 487.
60. Goedert, M., Fine, A., Hunt, S.P. Ullrich, A 1986) Nerve growth factor mRNA in peripheral and central rat tissues and in the human central nervous system: lesion effects in the rat brain and levels in Alzheimer's disease. Brain Res 387, 85 92.
61. Goedert, M., Fine, A., Dawbarn, D., Wilcock, G.K. Chao, M.V 1989) Nerve growth factor receptor mRNA distribution in human brain: normal levels in basal forebrain in Alzheimer's disease. Brain Res Mol Brain Res 5, 1 7.
62. Goldsbury, C., Mocanu, M.M., Thies, E., Kaether, C., Haass, C., Keller, P., Biernat, J., Mandelkow, E. Mandelkow, E.M 2006) Inhibition of APP trafficking by tau protein does not increase the generation of amyloid-beta peptides. Traffic 7, 873 888.
63. Gomez-Pinilla, F., Cummings, B.J. Cotman, C.W 1990) Induction of basic fibroblast growth factor in Alzheimer's disease pathology. Neuroreport 1, 211 214.
64. Gunawardena, S. Goldstein, L.S 2001) Disruption of axonal transport and neuronal viability by amyloid precursor protein mutations in Drosophila. Neuron 32, 389 401.
65. Hanneken, A., Frautschy, S., Galasko, D. Baird, A 1995) A fibroblast growth factor binding protein in human cerebral spinal fluid. Neuroreport 6, 886 888.
66. Hardy, J. Allsop, D 1991) Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends Pharmacol Sci 12, 383 388.
67. Hashimoto, Y., Kaneko, Y., Tsukamoto, E., Frankowski, H., Kouyama, K., Kita, Y., Niikura, T., Aiso, S., Bredesen, D.E., Matsuoka, M. Nishimoto, I 2004) Molecular characterization of neurohybrid cell death induced by Alzheimer's amyloid-beta peptides via p75NTR/PLAIDD. J Neurochem 90, 549 558.
68. Hasselmo, M.E. Stern, C.E 2006) Mechanisms underlying working memory for novel information. Trends Cogn Sci 10, 487 493.
69. Heese, K., Hock, C. Otten, U 1998) Inflammatory signals induce neurotrophin expression in human microglial cells. J Neurochem 70, 699 707.
70. Hellweg, R. Jockers-Scherubl, M 1994) Neurotrophic factors in memory disorders. Life Sci 55, 2165 2169.
71. Hellweg, R., Gericke, C.A., Jendroska, K., Hartung, H.D. Cervos-Navarro, J 1998) NGF content in the cerebral cortex of non-demented patients with amyloid-plaques and in symptomatic Alzheimer's disease. Int J Dev Neurosci 16, 787 794.
72. Hellweg, R., Lohmann, P., Huber, R., Kuhl, A. Riepe, M.W 2006) Spatial navigation in complex and radial mazes in APP23 animals and neurotrophin signaling as a biological marker of early impairment. Learn Mem 13, 63 71.
73. Heneka, M.T. O'Banion, M.K 2007) Inflammatory processes in Alzheimer's disease. J Neuroimmunol 184, 69 91.
74. Hiruma, H., Katakura, T., Takahashi, S., Ichikawa, T. Kawakami, T 2003) Glutamate and amyloid beta-protein rapidly inhibit fast axonal transport in cultured rat hippocampal neurons by different mechanisms. J Neurosci 23, 8967 8977.
75. Hock, C., Heese, K., Muller-Spahn, F., Hulette, C., Rosenberg, C. Otten, U 1998) Decreased trkA neurotrophin receptor expression in the parietal cortex of patients with Alzheimer's disease. Neurosci Lett 241, 151 154.
76. Hock, C., Heese, K., Hulette, C., Rosenberg, C. Otten, U 2000a) Region-specific neurotrophin imbalances in Alzheimer disease: decreased levels of brain-derived neurotrophic factor and increased levels of nerve growth factor in hippocampus and cortical areas. Arch Neurol 57, 846 851.
77. Hock, C., Heese, K., Muller-Spahn, F., Huber, P., Riesen, W., Nitsch, R.M. Otten, U 2000b) Increased cerebrospinal fluid levels of neurotrophin 3 (NT-3) in elderly patients with major depression. Mol Psychiatry 5, 510 513.
78. Hofman, A., Rocca, W.A., Brayne, C., Breteler, M.M., Clarke, M., Cooper, B., Copeland, J.R., Dartigues, J.F., da Silva Droux, A., Hagnell, O., Heere, T.J., Engedal, K., Jonker, C., Lindsay, J., Lobo, A., Mann, A.H., Mölsä, P.K., Morgan, K., O'Connor, D.W., Sulkava, R., Kay, D.W.K., Amaducci, L. For The Euroderm Prevalence Research Group 1991) The prevalence of dementia in Europe: a collaborative study of 1980-1990 findings. Eurodem Prevalence Research Group. Int J Epidemiol 20, 736 748.
79. Holsinger, R.M., Schnarr, J., Henry, P., Castelo, V.T. Fahnestock, M 2000) Quantitation of BDNF mRNA in human parietal cortex by competitive reverse transcription-polymerase chain reaction: decreased levels in Alzheimer's disease. Brain Res Mol Brain Res 76, 347 354.
80. Hu, X.Y., Zhang, H.Y., Qin, S., Xu, H., Swaab, D.F. Zhou, J.N 2002) Increased p75(NTR) expression in hippocampal neurons containing hyperphosphorylated tau in Alzheimer patients. Exp Neurol 178, 104 111.
81. Huang, R., Huang, J., Cathcart, H., Smith, S. Poduslo, S.E 2007) Genetic variants in brain-derived neurotrophic factor associated with Alzheimer's disease. J Med Genet 44 e66.
82. Ishihara, T., Hong, M., Zhang, B., Nakagawa, Y., Lee, M.K., Trojanowski, J.Q. Lee, V.M 1999) Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform. Neuron 24, 751 762.
83. Jankowsky, J.L., Xu, G., Fromholt, D., Gonzales, V. Borchelt, D.R 2003) Environmental enrichment exacerbates amyloid plaque formation in a transgenic mouse model of Alzheimer disease. J Neuropathol Exp Neurol 62, 1220 1227.
84. Jarvik, L. Greenson, H 1987) About a peculiar disease of the cerebral cortex. By Alois Alzheimer, 1907 (Translated by L. Jarvik and H. Greenson). Alzheimer Dis Assoc Disord 1, 3 8.
85. Jette, N., Cole, M.S. Fahnestock, M 1994) NGF mRNA is not decreased in frontal cortex from Alzheimer's disease patients. Brain Res Mol Brain Res 25, 242 250.
86. Jin, K., Sun, Y., Xie, L., Batteur, S., Mao, X.O., Smelick, C., Logvinova, A. Greenberg, D.A 2003) Neurogenesis and aging: FGF-2 and HB-EGF restore neurogenesis in hippocampus and subventricular zone of aged mice. Aging Cell 2, 175 183.
87. Johnson-Farley, N.N., Patel, K., Kim, D. Cowen, D.S 2007) Interaction of FGF-2 with IGF-1 and BDNF in stimulating Akt, ERK, and neuronal survival in hippocampal cultures. Brain Res 1154, 40 49.
88. Kar, S., Slowikowski, S.P., Westaway, D. Mount, H.T 2004) Interactions between beta-amyloid and central cholinergic neurons: implications for Alzheimer's disease. J Psychiatry Neurosci 29, 427 441.
89. Kasa, P., Rakonczay, Z. Gulya, K 1997) The cholinergic system in Alzheimer's disease. Prog Neurobiol 52, 511 535.
90. Kato, T., Sasaki, H., Katagiri, T., Sasaki, H., Koiwai, K., Youki, H., Totsuka, S. Ishii, T 1991) The binding of basic fibroblast growth factor to Alzheimer's neurofibrillary tangles and senile plaques. Neurosci Lett 122, 33 36.
91. Kayed, R., Head, E., Thompson, J.L., McIntire, T.M., Milton, S.C., Cotman, C.W. Glabe, C.G 2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300, 486 489.
92. Kerwin, J.M., Morris, C.M., Perry, R.H. Perry, E.K 1992) Hippocampal nerve growth factor receptor immunoreactivity in patients with Alzheimer's and Parkinson's disease. Neurosci Lett 143, 101 104.
93. Kiprianova, I., Schindowski, K., von Bohlen und Halbach, O., Krause, S., Dono, R., Schwaninger, M. Unsicker, K 2004) Enlarged infarct volume and loss of BDNF mRNA induction following brain ischemia in mice lacking FGF-2. Exp Neurol 189, 252 260.
94. Klenk, J., Rapp, K., Buchele, G., Keil, U. Weiland, S.K 2007) Increasing life expectancy in Germany: quantitative contributions from changes in age- and disease-specific mortality. Eur J Public Health. doi: 10.1093/eurpub/ckm024.
95. Kokubo, H., Kayed, R., Glabe, C.G. Yamaguchi, H 2005) Soluble Abeta oligomers ultrastructurally localize to cell processes and might be related to synaptic dysfunction in Alzheimer's disease brain. Brain Res 1031, 222 228.
96. Kraemer, B.C., Zhang, B., Leverenz, J.B., Thomas, J.H., Trojanowski, J.Q. Schellenberg, G.D 2003) Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy. Proc Natl Acad Sci U S A 100, 9980 9985.
97. Kuner, P. Hertel, C 1998) NGF induces apoptosis in a human neuroblastoma cell line expressing the neurotrophin receptor p75NTR. J Neurosci Res 54, 465 474.
98. Kunugi, H., Hattori, M., Ueki, A., Isse, K., Hirasawa, H. Nanko, S 1998) Possible association of missense mutation (Gly[-63]Glu) of the neurotrophin-3 gene with Alzheimer's disease in Japanese. Neurosci Lett 241, 65 67.
99. Kunugi, H., Ueki, A., Otsuka, M., Isse, K., Hirasawa, H., Kato, N., Nabika, T., Kobayashi, S. Nanko, S 2001) A novel polymorphism of the brain-derived neurotrophic factor (BDNF) gene associated with late-onset Alzheimer's disease. Mol Psychiatry 6, 83 86.
100. Lang, U.E., Muhlbacher, M., Hesselink, M.B., Zajaczkowski, W., Danysz, W., Danker-Hopfe, H. Hellweg, R 2004) No nerve growth factor response to treatment with memantine in adult rats. J Neural Transm 111, 181 190.
101. Lazarov, O., Lee, M., Peterson, D.A. Sisodia, S.S 2002) Evidence that synaptically released beta-amyloid accumulates as extracellular deposits in the hippocampus of transgenic mice. J Neurosci 22, 9785 9793.
102. Lazarov, O., Robinson, J., Tang, Y.P., Hairston, I.S., Korade-Mirnics, Z., Lee, V.M., Hersh, L.B., Sapolsky, R.M., Mirnics, K. Sisodia, S.S 2005) Environmental enrichment reduces Abeta levels and amyloid deposition in transgenic mice. Cell 120, 701 713.
103. Lee, E.B., Zhang, B., Liu, K., Greenbaum, E.A., Doms, R.W., Trojanowski, J.Q. Lee, V.M 2005a) BACE overexpression alters the subcellular processing of APP and inhibits Ab deposition in vivo. J Cell Biol 168, 291 302.
104. Lee, J., Fukumoto, H., Orne, J., Klucken, J., Raju, S., Vanderburg, C.R., Irizarry, M.C., Hyman, B.T. Ingelsson, M 2005b) Decreased levels of BDNF protein in Alzheimer temporal cortex are independent of BDNF polymorphisms. Exp Neurol 194, 91 96.
105. Lesné, S., Gabriel, C., Nelson, D.A., White, E., Mackenzie, E.T., Vivien, D., Buisson, A. (2005) Akt-dependent expression of NAIP-1 protects neurons against amyloid-β toxicity. J Biol Chem 280, 24941 24947.
106. Lewis, J., McGowan, E., Rockwood, J., Melrose, H., Nacharaju, P., Van Slegtenhorst, M., Gwinn-Hardy, K., Paul Murphy, M., Baker, M., Yu, X., Duff, K., Hardy, J., Corral, A., Lin, W.L., Yen, S.H., Dickson, D.W., Davies, P. Hutton, M 2000) Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat Genet 25, 402 405.
107. Li, Y., Rowland, C., Tacey, K., Catanese, J., Sninsky, J., Hardy, J., Powell, J., Lovestone, S., Morris, J.C., Thal, L., Goate, A., Owen, M., Williams, J. Grupe, A 2005) The BDNF Val66Met polymorphism is not associated with late onset Alzheimer's disease in three case-control samples. Mol Psychiatry 10, 809 810.
108. Loy, R., Heyer, D., Clagett-Dame, M. DiStefano, P.S 1990) Localization of NGF receptors in normal and Alzheimer's basal forebrain with monoclonal antibodies against the truncated form of the receptor. J Neurosci Res 27, 651 664.
109. Lue, L.F., Kuo, Y.M., Roher, A.E., Brachova, L., Shen, Y., Sue, L., Beach, T., Kurth, J.H., Rydel, R.E. Rogers, J 1999) Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am J Pathol 155, 853 862.
110. Mahley, R.W., Weisgraber, K.H. Huang, Y 2006) Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease. Proc Natl Acad Sci U S A 103, 5644 5651.
111. Mai, L., Jope, R.S. Li, X 2002) BDNF-mediated signal transduction is modulated by GSK3beta and mood stabilizing agents. J Neurochem 82, 75 83.
112. Maloney, M.T., Minamide, L.S., Kinley, A.W., Boyle, J.A. Bamburg, J.R 2005) Beta-secretase-cleaved amyloid precursor protein accumulates at actin inclusions induced in neurons by stress or amyloid beta: a feedforward mechanism for Alzheimer's disease. J Neurosci 25, 11313 11321.
113. Mandelkow, E.M., Thies, E., Trinczek, B., Biernat, J. Mandelkow, E 2004) MARK/PAR1 kinase is a regulator of microtubule-dependent transport in axons. J Cell Biol 167, 99 110.
114. Manji, H.K., Moore, G.J. Chen, G 1999) Lithium at 50: have the neuroprotective effects of this unique cation been overlooked? Biol Psychiatry 46, 929 940.
115. Marvanova, M., Lakso, M., Pirhonen, J., Nawa, H., Wong, G. Castren, E 2001) The neuroprotective agent memantine induces brain-derived neurotrophic factor and trkB receptor expression in rat brain. Mol Cell Neurosci 18, 247 258.
116. Matsushita, S., Arai, H., Matsui, T., Yuzuriha, T., Urakami, K., Masaki, T. Higuchi, S 2005) Brain-derived neurotrophic factor gene polymorphisms and Alzheimer's disease. J Neural Transm 112, 703 711.
117. Michalski, B. Fahnestock, M 2003) Pro-brain-derived neurotrophic factor is decreased in parietal cortex in Alzheimer's disease. Brain Res Mol Brain Res 111, 148 154.
118. Mobley, W.C., Neve, R.L., Prusiner, S.B. McKinley, M.P 1988) Nerve growth factor increases mRNA levels for the prion protein and the beta-amyloid protein precursor in developing hamster brain. Proc Natl Acad Sci U S A 85, 9811 9815.
119. Mudher, A., Shepherd, D., Newman, T.A., Mildren, P., Jukes, J.P., Squire, A., Mears, A., Drummond, J.A., Berg, S., MacKay, D., Asuni, A.A., Bhat, R. Lovestone, S 2004) GSK-3beta inhibition reverses axonal transport defects and behavioural phenotypes in Drosophila. Mol Psychiatry 9, 522 530.
120. Mufson, E.J., Conner, J.M. Kordower, J.H 1995) Nerve growth factor in Alzheimer's disease: defective retrograde transport to nucleus basalis. Neuroreport 6, 1063 1066.
121. Mufson, E.J., Lavine, N., Jaffar, S., Kordower, J.H., Quirion, R. Saragovi, H.U 1997) Reduction in p140-TrkA receptor protein within the nucleus basalis and cortex in Alzheimer's disease. Exp Neurol 146, 91 103.
122. Mufson, E.J., Ma, S.Y., Cochran, E.J., Bennett, D.A., Beckett, L.A., Jaffar, S., Saragovi, H.U. Kordower, J.H 2000) Loss of nucleus basalis neurons containing trkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer's disease. J Comp Neurol 427, 19 30.
123. Mufson, E.J., Ma, S.Y., Dills, J., Cochran, E.J., Leurgans, S., Wuu, J., Bennett, D.A., Jaffar, S., Gilmor, M.L., Levey, A.I. Kordower, J.H 2002) Loss of basal forebrain P75(NTR) immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease. J Comp Neurol 443, 136 153.
124. Mufson, E.J., Ginsberg, S.D., Ikonomovic, M.D. DeKosky, S.T 2003) Human cholinergic basal forebrain: chemoanatomy and neurologic dysfunction. J Chem Neuroanat 26, 233 242.
125. Murase, K., Igarashi, K. Hayashi, K 1994) Neurotrophin-3 (NT-3) levels in the developing rat nervous system and in human samples. Clin Chim Acta 227, 23 36.
126. Murer, M.G., Boissiere, F., Yan, Q., Hunot, S., Villares, J., Faucheux, B., Agid, Y., Hirsch, E. Raisman-Vozari, R 1999) An immunohistochemical study of the distribution of brain-derived neurotrophic factor in the adult human brain, with particular reference to Alzheimer's disease. Neuroscience 88, 1015 1032.
127. Murer, M.G., Yan, Q. Raisman-Vozari, R 2001) Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease. Prog Neurobiol 63, 71 124.
128. Muresan, Z. Muresan, V 2006) Neuritic deposits of amyloid-b peptide in a subpopulation of central nervous system-derived neuronal cells. Mol Cell Biol 26, 4982 4997.
129. Nacmias, B., Piccini, C., Bagnoli, S., Tedde, A., Cellini, E., Bracco, L. Sorbi, S 2004) Brain-derived neurotrophic factor, apolipoprotein E genetic variants and cognitive performance in Alzheimer's disease. Neurosci Lett 367, 379 383.
130. Narisawa-Saito, M., Wakabayashi, K., Tsuji, S., Takahashi, H. Nawa, H 1996) Regional specificity of alterations in NGF, BDNF and NT-3 levels in Alzheimer's disease. Neuroreport 7, 2925 2928.
131. Nishimura, M., Kuno, S., Kaji, R. Kawakami, H 2005) Brain-derived neurotrophic factor gene polymorphisms in Japanese patients with sporadic Alzheimer's disease, Parkinson's disease, and multiple system atrophy. Mov Disord 20, 1031 1033.
132. Nuydens, R., Dispersyn, G., de Jong, M., van den Kieboom, G., Borgers, M. Geerts, H 1997) Aberrant tau phosphorylation and neurite retraction during NGF deprivation in PC12 cells. Biochem Biophys Res Commun 240, 687 691.
133. Olin, D., MacMurray, J. Comings, D.E 2005) Risk of late-onset Alzheimer's disease associated with BDNF C270T polymorphism. Neurosci Lett 381, 275 278.
134. Olivieri, G., Novakovic, M., Savaskan, E., Meier, F., Baysang, G., Brockhaus, M. Muller-Spahn, F 2002) The effects of beta-estradiol on SHSY5Y neuroblastoma cells during heavy metal induced oxidative stress, neurotoxicity and beta-amyloid secretion. Neuroscience 113, 849 855.
135. Olivieri, G., Otten, U., Meier, F., Baysang, G., Dimitriades-Schmutz, B., Muller-Spahn, F. Savaskan, E 2003) Beta-amyloid modulates tyrosine kinase B receptor expression in SHSY5Y neuroblastoma cells: influence of the antioxidant melatonin. Neuroscience 120, 659 665.
136. Origlia, N., Capsoni, S., Domenici, L. Cattaneo, A 2006) Time window in cholinomimetic ability to rescue long-term potentiation in neurodegenerating anti-nerve growth factor mice. J Alzheimers Dis 9, 59 68.
137. Patapoutian, A. Reichardt, L.F 2001) Trk receptors: mediators of neurotrophin action. Curr Opin Neurobiol 11, 272 280.
138. Peng, S., Wuu, J., Mufson, E.J. Fahnestock, M 2004) Increased proNGF levels in subjects with mild cognitive impairment and mild Alzheimer disease. J Neuropathol Exp Neurol 63, 641 649.
139. Peng, S., Wuu, J., Mufson, E.J. Fahnestock, M 2005) Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease. J Neurochem 93, 1412 1421.
140. Perry, E.K., Johnson, M., Kerwin, J.M., Piggott, M.A., Court, J.A., Shaw, P.J., Ince, P.G., Brown, A. Perry, R.H 1992) Convergent cholinergic activities in aging and Alzheimer's disease. Neurobiol Aging 13, 393 400.
141. Perry, E.K., Irving, D., Kerwin, J.M., McKeith, I.G., Thompson, P., Collerton, D., Fairbairn, A.F., Ince, P.G., Morris, C.M., Cheng, A.V., Perry, R.H 1993) Cholinergic transmitter and neurotrophic activities in Lewy body dementia: similarity to Parkinson's and distinction from Alzheimer disease. Alzheimer Dis Assoc Disord 7, 69 79.
142. Phillips, H.S., Hains, J.M., Armanini, M., Laramee, G.R., Johnson, S.A. Winslow, J.W 1991) BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease. Neuron 7, 695 702.
143. Pike, C.J., Cummings, B.J., Monzavi, R. Cotman, C.W 1994) Beta-amyloid-induced changes in cultured astrocytes parallel reactive astrocytosis associated with senile plaques in Alzheimer's disease. Neuroscience 63, 517 531.
144. Polvikoski, T., Sulkava, R., Haltia, M., Kainulainen, K., Vuorio, A., Verkkoniemi, A., Niinisto, L., Halonen, P. Kontula, K 1995) Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein. N Engl J Med 333, 1242 1247.
145. Probst, A., Gotz, J., Wiederhold, K.H., Tolnay, M., Mistl, C., Jaton, A.L., Hong, M., Ishihara, T., Lee, V.M., Trojanowski, J.Q., Jakes, R., Crowther, R.A., Spillantini, M.G., Burki, K. Goedert, M 2000) Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein. Acta Neuropathol (Berl) 99, 469 481.
146. Qiu, Z., Naten, D.L., Liston, J.C., Yess, J. Rebeck, G.W 2001) A novel approach for studying endogenous ab processing using cultured primary neurons isolated from APP transgenic mice. Exp Neurol 170, 186 194.
147. Riemenschneider, M., Schwarz, S., Wagenpfeil, S., Diehl, J., Muller, U., Forstl, H. Kurz, A 2002) A polymorphism of the brain-derived neurotrophic factor (BDNF) is associated with Alzheimer's disease in patients lacking the Apolipoprotein E epsilon4 allele. Mol Psychiatry 7, 782 785.
148. Robakis, N.K., Anderson, J.P., Refolo, L.M. Wallace, W 1991) Expression of the Alzheimer amyloid precursor in brain tissue and effects of NGF and EGF on its metabolism. Clin Neuropharmacol 14 (Suppl. 1 S15 S23.
149. Rossner, S., Ueberham, U., Schliebs, R., Perez-Polo, J.R. Bigl, V 1998) p75 and TrkA receptor signaling independently regulate amyloid precursor protein mRNA expression, isoform composition, and protein secretion in PC12 cells. J Neurochem 71, 757 766.
150. Ruiz-Leon, Y. Pascual, A 2004) Regulation of beta-amyloid precursor
151. Saarela, M.S., Lehtimaki, T., Rinne, J.O., Huhtala, H., Rontu, R., Hervonen, A., Roytta, M., Ahonen, J.P. Mattila, K.M 2006) No association between the brain-derived neurotrophic factor 196 G>A or 270 C>T polymorphisms and Alzheimer's or Parkinson's disease. Folia Neuropathol 44, 12 16.
152. Sadot, E., Heicklen-Klein, A., Barg, J., Lazarovici, P. Ginzburg, I 1996) Identification of a tau promoter region mediating tissue-specific-regulated expression in PC12 cells. J Mol Biol 256, 805 812.
153. Saez, E.T., Pehar, M., Vargas, M.R., Barbeito, L. Maccioni, R.B 2006) Production of nerve growth factor by beta-amyloid-stimulated astrocytes induces p75(NTR)-dependent tau hyperphosphorylation in cultured hippocampal neurons. J Neurosci Res 84, 1098 1106.
154. Salehi, A., Verhaagen, J., Dijkhuizen, P.A. Swaab, D.F 1996) Co-localization of high-affinity neurotrophin receptors in nucleus basalis of Meynert neurons and their differential reduction in Alzheimer's disease. Neuroscience 75, 373 387.
155. Salehi, A., Ocampo, M., Verhaagen, J. Swaab, D.F 2000) P75 neurotrophin receptor in the nucleus basalis of meynert in relation to age, sex, and Alzheimer's disease. Exp Neurol 161, 245 258.
156. Salehi, A., Delcroix, J.D., Belichenko, P.V., Zhan, K., Wu, C., Valletta, J.S., Takimoto-Kimura, R., Kleschevnikov, A.M., Sambamurti, K., Chung, P.P., Xia, W., Villar, A., Campbell, W.A., Kulnane, L.S., Nixon, R.A., Lamb, B.T., Epstein, C.J., Stokin, G.B., Goldstein, L.S., Mobley, W.C. (2006) Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration. Neuron 51, 29 42.
157. Savaskan, E., Muller-Spahn, F., Olivieri, G., Bruttel, S., Otten, U., Rosenberg, C., Hulette, C. Hock, C 2000) Alterations in trk A, trk B and trk C receptor immunoreactivities in parietal cortex and cerebellum in Alzheimer's disease. Eur Neurol 44, 172 180.
158. Scott, S.A., Mufson, E.J., Weingartner, J.A., Skau, K.A. Crutcher, K.A 1995) Nerve growth factor in Alzheimer's disease: increased levels throughout the brain coupled with declines in nucleus basalis. J Neurosci 15, 6213 6221.
159. Seitz, A., Kojima, H., Oiwa, K., Mandelkow, E.M., Song, Y.H. Mandelkow, E 2002) Single-molecule investigation of the interference between kinesin, tau and MAP2c. EMBO J 21, 4896 4905.
160. Selkoe, D.J 2001) Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 81, 741 766.
161. Sergeant, N., Delacourte, A. Buee, L 2005) Tau protein as a differential biomarker of tauopathies. Biochim Biophys Acta 1739, 179 197.
162. Shelton, S.B. Johnson, G.V 2001) Tau and HMW tau phosphorylation and compartmentalization in apoptotic neuronal PC12 cells. J Neurosci Res 66, 203 213.
163. Shen, Z.X 2004) Brain cholinesterases: III. Future perspectives of AD research and clinical practice. Med Hypotheses 63, 298 307.
164. Sheng, J.G., Price, D.L. Koliatsos, V.E 2002) Disruption of corticocortical connections ameliorates amyloid burden in terminal fields in a transgenic model of Ab amyloidosis. J Neurosci 22, 9794 9799.
165. Siedlak, S.L., Cras, P., Kawai, M., Richey, P. Perry, G 1991) Basic fibroblast growth factor binding is a marker for extracellular neurofibrillary tangles in Alzheimer disease. J Histochem Cytochem 39, 899 904.
166. Siegel, G.J. Chauhan, N.B 2000) Neurotrophic factors in Alzheimer's and Parkinson's disease brain. Brain Res Brain Res Rev 33, 199 227.
167. Sokol, D.K., Chen, D., Farlow, M.R., Dunn, D.W., Maloney, B., Zimmer, J.A. Lahiri, D.K 2006) High levels of Alzheimer beta-amyloid precursor protein (APP) in children with severely autistic behavior and aggression. J Child Neurol 21, 444 449.
168. Soto, I., Rosenthal, J.J., Blagburn, J.M. Blanco, R.E 2006) Fibroblast growth factor 2 applied to the optic nerve after axotomy up-regulates BDNF and TrkB in ganglion cells by activating the ERK and PKA signaling pathways. J Neurochem 96, 82 96.
169. Stamer, K., Vogel, R., Thies, E., Mandelkow, E. Mandelkow, E.M 2002) Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress. J Cell Biol 156, 1051 1063.
170. Stieber, A., Mourelatos, Z. Gonatas, N.K 1996) In Alzheimer's disease the Golgi apparatus of a population of neurons without neurofibrillary tangles is fragmented and atrophic. Am J Pathol 148, 415 426.
171. Stokin, G.B., Lillo, C., Falzone, T.L., Brusch, R.G., Rockenstein, E., Mount, S.L., Raman, R., Davies, P., Masliah, E., Williams, D.S. Goldstein, L.S 2005) Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science 307, 1282 1288.
172. Svendsen, C.N., Cooper, J.D. Sofroniew, M.V 1991) Trophic factor effects on septal cholinergic neurons. Ann N Y Acad Sci 640, 91 94.
173. Takahashi, R.H., Almeida, C.G., Kearney, P.F., Yu, F., Lin, M.T., Milner, T.A. Gouras, G.K 2004) Oligomerization of Alzheimer's beta-amyloid within processes and synapses of cultured neurons and brain. J Neurosci 24, 3592 3599.
174. Takami, K., Matsuo, A., Terai, K., Walker, D.G., McGeer, E.G. McGeer, P.L 1998) Fibroblast growth factor receptor-1 expression in the cortex and hippocampus in Alzheimer's disease. Brain Res 802, 89 97.
175. Tatebayashi, Y., Iqbal, K. Grundke-Iqbal, I 1999) Dynamic regulation of expression and phosphorylation of tau by fibroblast growth factor-2 in neural progenitor cells from adult rat hippocampus. J Neurosci 19, 5245 5254.
176. Tatebayashi, Y., Lee, M.H., Li, L., Iqbal, K. Grundke-Iqbal, I 2003) The dentate gyrus neurogenesis: a therapeutic target for Alzheimer's disease. Acta Neuropathol (Berl) 105, 225 232.
177. Tatebayashi, Y., Haque, N., Tung, Y.C., Iqbal, K. Grundke-Iqbal, I 2004) Role of tau phosphorylation by glycogen synthase kinase-3beta in the regulation of organelle transport. J Cell Sci 117, 1653 1663.
178. Thoenen, H., Zafra, F., Hengerer, B. Lindholm, D 1991) The synthesis of nerve growth factor and brain-derived neurotrophic factor in hippocampal and cortical neurons is regulated by specific transmitter systems. Ann N Y Acad Sci 640, 86 90.
179. Tong, L., Shen, H., Perreau, V.M., Balazs, R. Cotman, C.W 2001a) Effects of exercise on gene-expression profile in the rat hippocampus. Neurobiol Dis 8, 1046 1056.
180. Tong, L., Thornton, P.L., Balazs, R. Cotman, C.W 2001b) Beta-amyloid-(1-42) impairs activity-dependent cAMP-response element-binding protein signaling in neurons at concentrations in which cell survival is not compromised. J Biol Chem 276, 17301 17306.
181. Tong, L., Balazs, R., Thornton, P.L. Cotman, C.W 2004) Beta-amyloid peptide at sublethal concentrations downregulates brain-derived neurotrophic factor functions in cultured cortical neurons. J Neurosci 24, 6799 6809.
182. Treanor, J.J., Dawbarn, D., Allen, S.J., MacGowan, S.H. Wilcock, G.K 1991) Low affinity nerve growth factor receptor binding in normal and Alzheimer's disease basal forebrain. Neurosci Lett 121, 73 76.
183. Tsai, J., Grutzendler, J., Duff, K. Gan, W.B 2004a) Fibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal branches. Nat Neurosci 7, 1181 1183.
184. Tsai, S.J., Hong, C.J., Liu, H.C., Liu, T.Y., Hsu, L.E. Lin, C.H 2004b) Association analysis of brain-derived neurotrophic factor Val66Met polymorphisms with Alzheimer's disease and age of onset. Neuropsychobiology 49, 10 12.
185. Tsai, S.J., Hong, C.J., Liu, H.C., Liu, T.Y. Liou, Y.J 2006) The brain-derived neurotrophic factor gene as a possible susceptibility candidate for Alzheimer's disease in a Chinese population. Dement Geriatr Cogn Disord 21, 139 143.
186. Tsukamoto, E., Hashimoto, Y., Kanekura, K., Niikura, T., Aiso, S. Nishimoto, I 2003) Characterization of the toxic mechanism triggered by Alzheimer's amyloid-beta peptides via p75 neurotrophin receptor in neuronal hybrid cells. J Neurosci Res 73, 627 636.
187. Tuszynski, M.H., Smith, D.E., Roberts, J., McKay, H. Mufson, E 1998) Targeted intraparenchymal delivery of human NGF by gene transfer to the primate basal forebrain for 3 months does not accelerate beta-amyloid plaque deposition. Exp Neurol 154, 573 582.
188. Tuszynski, M.H., Thal, L., Pay, M., Salmon, D.P., U, H.S., Bakay, R., Patel, P., Blesch, A., Vahlsing, H.L., Ho, G., Tong, G., Potkin, S.G., Fallon, J., Hansen, L., Mufson, E.J., Kordower, J.H., Gall, C. Conner, J 2005) A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease. Nat Med 11, 551 555.
189. Venero, J.L., Knusel, B., Beck, K.D. Hefti, F 1994) Expression of neurotrophin and trk receptor genes in adult rats with fimbria transections: effect of intraventricular nerve growth factor and brain-derived neurotrophic factor administration. Neuroscience 59, 797 815.
190. Vepsalainen, S., Castren, E., Helisalmi, S., Iivonen, S., Mannermaa, A., Lehtovirta, M., Hanninen, T., Soininen, H. Hiltunen, M 2005) Genetic analysis of BDNF and TrkB gene polymorphisms in Alzheimer's disease. J Neurol 252, 423 428.
191. Verdile, G., Fuller, S., Atwood, C.S., Laws, S.M., Gandy, S.E. Martins, R.N 2004) The role of beta amyloid in Alzheimer's disease: still a cause of everything or the only one who got caught? Pharmacol Res 50, 397 409.
192. Villa, A., Latasa, M.J. Pascual, A 2001) Nerve growth factor modulates the expression and secretion of beta-amyloid precursor protein through different mechanisms in PC12 cells. J Neurochem 77, 1077 1084.
193. Wirths, O., Weis, J., Kayed, R., Saido, T.C. Bayer, T.A 2006) Age-dependent axonal degeneration in an Alzheimer mouse model. Neurobiol Aging 8, 1689 1699.
194. Wolf, S.A., Kronenberg, G., Lehmann, K., Blankenship, A., Overall, R., Staufenbiel, M. Kempermann, G 2006) Cognitive and physical activity differently modulate disease progression in the amyloid precursor protein (APP)-23 model of Alzheimer's disease. Biol Psychiatry 60, 1314 1323.
195. Wolfe, M.S. Kopan, R 2004) Intramembrane proteolysis: theme and variations. Science 305, 1119 1123.
196. Wynn, Z.J. Cummings, J.L 2004) Cholinesterase inhibitor therapies and neuropsychiatric manifestations of Alzheimer's disease. Dement Geriatr Cogn Disord 17, 100 108.
197. Yamada, T., Yoshiyama, Y. Kawaguchi, N 1997) Expression of activating transcription factor-2 (ATF-2), one of the cyclic AMP response element (CRE) binding proteins, in Alzheimer disease and non-neurological brain tissues. Brain Res 749, 329 334.
198. Yamamoto-Sasaki, M., Ozawa, H., Saito, T., Rosler, M. Riederer, P 1999) Impaired phosphorylation of cyclic AMP response element binding protein in the hippocampus of dementia of the Alzheimer type. Brain Res 824, 300 303.
199. Yankner, B.A., Caceres, A. Duffy, L.K 1990) Nerve growth factor potentiates the neurotoxicity of beta amyloid. Proc Natl Acad Sci U S A 87, 9020 9023.